Fatty Liver and Cough: Causes and When to Act

Fatty liver disease and cough are two conditions that often appear together, yet the relationship between them is frequently misunderstood. Fatty liver disease, now formally classified as metabolic dysfunction-associated steatotic liver disease (MASLD), does not directly cause a cough, but shared metabolic risk factors such as obesity, type 2 diabetes and gastro-oesophageal reflux disease create conditions in which both can occur simultaneously. In advanced liver disease, complications such as hepatic hydrothorax can produce respiratory symptoms. Understanding the indirect links between these conditions helps ensure the correct diagnosis is reached and appropriate treatment is started promptly.

Can fatty liver disease actually cause a cough?

Fatty liver disease does not directly cause a cough, but in advanced disease, complications such as hepatic hydrothorax can compress lung tissue and produce a persistent cough. Shared metabolic risk factors, particularly obesity, independently increase the likelihood of cough-causing conditions such as GORD.

Fatty liver disease does not directly cause a cough, but the two symptoms can coexist through shared underlying mechanisms rather than a straightforward cause-and-effect relationship. Fatty liver disease is now formally classified under the term metabolic dysfunction-associated steatotic liver disease (MASLD), which describes fat accumulation in liver cells driven by metabolic risk factors such as obesity, type 2 diabetes, high blood pressure and dyslipidaemia.^[1][2] It is important to note that MASLD is defined by metabolic dysfunction and is a separate classification from alcohol-related liver disease (ALD) and the intermediate category MetALD, which involves both metabolic risk and significant alcohol intake.^[2][3] The liver itself has no cough receptors, so liver inflammation or fat accumulation cannot trigger the cough reflex directly.

However, there are indirect pathways worth understanding. In advanced liver disease, a condition called hepatic hydrothorax can develop, where fluid from the abdominal cavity (ascites) passes through small defects in the diaphragm and collects in the pleural space around the lungs.^[6][7] This pleural effusion can compress lung tissue and produce a persistent, dry cough alongside breathlessness. This complication is more associated with cirrhosis than with early-stage fatty liver disease.

In rarer cases of advanced liver disease, hepatopulmonary syndrome (where abnormal blood vessel changes in the lungs impair oxygen exchange) and portopulmonary hypertension (raised blood pressure in the pulmonary circulation linked to portal hypertension) can also produce respiratory symptoms including breathlessness and, in some cases, cough.^[9][10] These are uncommon but clinically important conditions.

In milder, non-cirrhotic fatty liver disease, a direct link to cough is not established. What is more common is that both conditions share the same risk factors, particularly obesity and metabolic syndrome, which independently increase the likelihood of gastro-oesophageal reflux disease (GORD), obstructive sleep apnoea and asthma, all of which are well-recognised causes of chronic cough. So while fatty liver disease itself is not a recognised cause of coughing, the broader metabolic picture that drives it frequently creates conditions in which cough becomes more likely.

What other conditions link liver problems and persistent coughing?

GORD, obstructive sleep apnoea, sarcoidosis, alcohol-related liver disease and ACE inhibitor use can all simultaneously affect the liver and cause a persistent cough. Rarer complications of advanced liver disease, including hepatopulmonary syndrome, also produce respiratory symptoms.

Several conditions can simultaneously affect the liver and produce a persistent cough, making it important not to attribute either symptom to a single cause without proper investigation. The most clinically significant of these shared conditions include the following:

• Gastro-oesophageal reflux disease (GORD): Strongly associated with both fatty liver disease and chronic cough. Acid reflux irritates the larynx and airways, triggering a dry, persistent cough, particularly at night or after meals. Obesity, a key driver of MASLD, also worsens GORD.

• Obstructive sleep apnoea (OSA): Common in people with metabolic syndrome, OSA is linked to fatty liver disease and can cause nocturnal coughing, throat clearing and daytime fatigue.

• Hepatopulmonary syndrome and portopulmonary hypertension: These are rarer but important complications of advanced liver disease and portal hypertension. They primarily cause breathlessness but can be accompanied by cough, and they require specialist assessment.

• Sarcoidosis: This inflammatory condition can affect both the liver and the lungs, causing granulomas in both organs. Pulmonary sarcoidosis frequently presents with a dry cough.

• Primary biliary cholangitis (PBC) and autoimmune hepatitis: These autoimmune liver conditions can occasionally occur alongside other autoimmune conditions affecting the lungs, such as interstitial lung disease.

• Alcohol-related liver disease: Heavy alcohol use damages both the liver and the respiratory tract, increasing susceptibility to recurrent chest infections and chronic bronchitis, both of which cause cough.

• Medication side effects: Some medicines used in the management of conditions associated with liver disease, particularly ACE inhibitors prescribed for hypertension or cardiovascular risk, are a very common cause of a persistent dry cough.^[14][15] If you suspect a medicine is causing your cough, speak to your GP before stopping it. You can also report suspected side effects of any medicine to the MHRA via the Yellow Card scheme at yellowcard.mhra.gov.uk.

Identifying which of these overlapping conditions is responsible for a cough requires careful clinical assessment rather than assumption.

How do doctors investigate an unexplained cough alongside liver disease?

Doctors take a structured history, perform blood tests including liver function tests and inflammatory markers, and arrange imaging such as chest X-ray or CT scan to identify the cause. NICE criteria guide urgent referral when haemoptysis or unexplained weight loss is present.

Doctors investigate an unexplained cough in someone with known liver disease by taking a structured history, performing a physical examination and requesting targeted investigations to identify the most likely cause. The history will focus on the character of the cough (dry or productive), its timing, any associated symptoms such as heartburn, breathlessness or weight loss, alcohol intake, smoking history and current medications, particularly ACE inhibitors.

Blood tests are usually the first step and may include liver function tests, full blood count, inflammatory markers such as C-reactive protein, and autoimmune antibodies if an autoimmune liver or lung condition is suspected. If the cough is productive, a sputum sample may be sent for culture to exclude infection.

Imaging plays an important role. A chest X-ray can identify pleural effusion, consolidation or enlarged lymph nodes. If the chest X-ray is inconclusive, a CT scan of the chest and abdomen may be requested to assess both the lungs and the liver in greater detail. An ultrasound of the abdomen is often used to evaluate the liver and detect ascites.

If GORD is suspected as the cause of cough and the person has typical reflux symptoms such as heartburn or regurgitation, a trial of a proton pump inhibitor may be recommended in line with NICE guidance on dyspepsia and GORD. UK respiratory guidance cautions that an empiric PPI trial is not routinely recommended for unexplained chronic cough in the absence of reflux symptoms. Spirometry may be arranged to assess lung function if asthma or chronic obstructive pulmonary disease is a possibility.

Where haemoptysis (coughing up blood) or unexplained weight loss is present, particularly in adults aged 40 or over, NICE guidance on suspected cancer (NG12) sets out criteria for urgent chest X-ray and two-week-wait referral that a GP will apply. In complex cases, referral to a respiratory physician or hepatologist may be appropriate to coordinate further investigation.

Managing fatty liver disease and its wider symptoms

Lifestyle modification, including sustained weight loss and increased physical activity, is the primary treatment for MASLD and addresses many associated conditions that contribute to cough. Coexisting GORD, sleep apnoea and ACE inhibitor-related cough each have specific management pathways in line with NICE guidance.

The most effective management of fatty liver disease centres on lifestyle modification, which also addresses many of the associated conditions that can contribute to a persistent cough. NICE guidance on non-alcoholic fatty liver disease (NG49), which covers the condition now reclassified internationally as MASLD, emphasises sustained weight loss, increased physical activity and dietary improvement as the primary interventions.^[1][24] Evidence from liver biopsy studies, cited in EASL and BSG guidance, indicates that a weight reduction of around 7 to 10 per cent of body weight can produce meaningful improvements in liver histology and metabolic markers, though the degree of benefit varies between individuals.

For individuals in whom obesity is a significant driver, structured weight management programmes may be recommended. In some cases, a GP or specialist may consider referral for pharmacological weight management support. Bolt Pharmacy is a GPhC-registered UK online pharmacy offering online weight-management consultations, with prescriber review and pharmacist support, where a clinician can assess which approach, if any, is clinically appropriate for an individual.

Managing coexisting conditions is equally important. GORD should be treated with dietary adjustments, weight loss and, where appropriate, acid-suppressing medication in line with NICE guidance. Sleep apnoea may require assessment for continuous positive airway pressure (CPAP) therapy in accordance with NICE guidance on obstructive sleep apnoea.^[22][23] If an ACE inhibitor is identified as the cause of a cough, a GP may consider switching to an angiotensin receptor blocker (ARB), which does not carry the same side effect profile, as set out in NICE hypertension guidance and the BNF.^[19][20]

Alcohol reduction or abstinence is essential in alcohol-related liver disease and can also reduce respiratory tract irritation. Regular monitoring of liver function, blood glucose and lipid levels helps to track disease progression and guide ongoing management. Patients should be supported to engage with structured follow-up, as fatty liver disease can progress silently without regular review.

When should you see a GP about a cough and liver concerns?

See a GP if a cough has persisted for more than three weeks, especially with known liver disease, or sooner if there is haemoptysis, unexplained weight loss, increasing breathlessness or jaundice. Call 999 for sudden severe breathlessness, chest pain or significant haemoptysis.

You should see a GP if a cough has persisted for more than three weeks, particularly if you have a known diagnosis of fatty liver disease or other liver condition, as a prolonged cough always warrants clinical assessment to identify its cause. NHS guidance advises that adults should see a GP if a cough lasts longer than three weeks, and this threshold is lower if there are additional concerning features.^[21]

Contact your GP promptly if you experience any of the following alongside a cough:

• Coughing up blood, even in small amounts

• Unexplained weight loss over a short period

• Increasing breathlessness at rest or on minimal exertion

• Swelling of the abdomen or legs, which may suggest fluid accumulation related to liver disease

• Yellowing of the skin or eyes (jaundice), indicating worsening liver function

• Night sweats or fever, which may point to infection or an inflammatory condition

If you are taking an ACE inhibitor and have developed a new dry cough, mention this to your GP, as a medication review may resolve the symptom without further investigation.

For urgent symptoms such as sudden severe breathlessness, chest pain or coughing up a significant amount of blood, call 999 or go to the nearest accident and emergency department immediately. For concerns that feel urgent but are not immediately life-threatening, NHS 111 can provide advice at any time of day or night.

Do not delay seeking advice on the assumption that a cough is unrelated to liver disease. Early assessment allows the correct diagnosis to be made and appropriate treatment to be started promptly.

Scientific References

1. Non-alcoholic fatty liver disease (NAFLD) [NG49].
2. Asia-Pacific perspectives on the steatotic liver disease (SLD) reclassification: balancing terminology, diagnostic criteria, and implementation.
3. MetALD: decoding the evolution of steatotic liver disease nomenclature and implications for clinical practice and beyond.
4. Comparison of prevalence of fatty liver disease according to the different nomenclatures of NAFLD, MAFLD, and MASLD in a large Iranian Population-based study.
5. AGA Clinical Practice Update on the Evaluation and Management of Metabolic Dysfunction- and Alcohol-Associated Liver Disease: Expert Review.
6. Hepatic hydrothorax as a manifestation of decompensated cirrhosis: An update on current management and future directions.
7. Hepatic hydrothorax: presentation of 3 cases with different therapeutic approaches.
8. Surgical Treatment of Hepatic Hydrothorax: A "Four-Step Approach".
9. Portopulmonary Hypertension and Hepatopulmonary Syndrome: Contrasting Pathophysiology and Implications for Liver Transplantation.
10. Disruption of Hepatic Sinusoidal Homeostasis Leads to Hepatopulmonary Syndrome.
11. Hepatopulmonary syndrome.
12. Portopulmonary Hypertension: An Updated Review.
13. Sarcoidosis.
14. ACE inhibitor-induced cough and bronchospasm. Incidence, mechanisms and management.
15. Pathophysiology of cough with angiotensin-converting enzyme inhibitors: How to explain within-class differences?.
16. ACEI-induced cough: A review of current evidence and its practical implications for optimal CV risk reduction.
17. Angiotensin-converting enzyme inhibitor-induced angioedema.
18. Suspected cancer: recognition and referral [NG12].
19. Drugs affecting the renin-angiotensin system - BNF - NICE.
20. Hypertension | Treatment summaries - BNF - NICE.
21. Cough.
22. Continuous positive airway pressure for the treatment of obstructive sleep apnoea/hypopnoea syndrome [TA139].
23. Obstructive sleep apnoea/hypopnoea syndrome and obesity hypoventilation syndrome [NG202].
24. Non-alcoholic fatty liver disease (NAFLD).

Frequently Asked Questions